3/27
08:02 am
cgtx
Cognition Therapeutics (CGTX) had its "buy" rating reaffirmed by Chardan Capital. They now have a $4.00 price target on the stock.
High
Report
Cognition Therapeutics (CGTX) had its "buy" rating reaffirmed by Chardan Capital. They now have a $4.00 price target on the stock.
3/27
07:58 am
cgtx
Rating for CGTX
High
Report
Rating for CGTX